Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant ...
ZADNA probe exposes costly executive spend amid cash decline By Simnikiwe Mzekandaba, IT in government editorJohannesburg, 20 Feb 2026An investigation uncovered weaknesses in ZADNA’s credit card ...
Lunch and learn sessions are a great way to make training and discussions a more interactive and engaging part of an ...
The rules and procedures for the city's Board of Directors now includes a policy about board member conduct along with ...
As Epstein fallout keeps hitting corporate America, it's evolving into leadership lessons on corporate integrity, crisis ...
If you have a jar of sun-dried tomatoes sitting in the back of your pantry gathering dust, we have a bunch of scrumptious ...
Three new books apply an economist’s lens — and language — to some of our most unruly phenomena, including war and nature ...
Some say we’ve entered a new age of AI-enabled scientific discovery. But human insight and creativity still can’t be ...
The Business & Financial Times on MSN
Business Compliance in 2026: Volving Reporting, Tax and Regulatory Requirements
In 2025, the government undertook comprehensive VAT reforms to improve the efficiency of tax administration and alleviate the tax burden on households and businesses. These reforms, passed under the ...
A "health-focused experience" inside ChatGPT is designed to help you understand medical information and prepare for ...
Luna Glamping reports growing demand for sleep retreat development, delivering innovative dome solutions for wellness ...
Pharmaceutical Technology on MSN
RNA-targeting small molecules: a new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results